Elisabeth Sandoval Little

Insider Reports History

Identity Names, identifiers, and filing context for this profile. 1 identity field
Reporting-owner location
Westlake Village, CA
SEC source record Original filing metadata and source links for verification. 1 source field
Latest reporting-owner signature
/s/ Jonathan Stone, Attorney-in-Fact for Elisabeth Little
Source: Latest parsed Forms 3/4/5 signature
Source evidence Original filing metadata and source links for verification. 1 source field
Transaction source note
Rows are grouped by transaction date from the original SEC filing. Open the aggregated insider activity page to review issuer-level activity across dates.

Reported holdings for Elisabeth Sandoval Little

Form 4 holding Director

PROCEPT BioRobotics Corp

Security class
Stock Option (Right to Buy)
Shares / value
5,853
Estimated value
$11,519
Report date
09 Jun 2026
Price
$4.56
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Intersect ENT, Inc.

Security class
Stock Options (Right to buy)
Shares / value
0
Estimated value
Report date
13 May 2022
Price
$28.25
Ownership
Direct
Underlying class
Common Stock
Underlying amount
Form 4 holding Director

Satsuma Pharmaceuticals, Inc.

Security class
Stock Option (right to buy)
Shares / value
0
Estimated value
Report date
08 Jun 2023
Price
Ownership
Direct
Underlying class
Common Stock
Underlying amount

Insider Reports Filed by Elisabeth Sandoval Little

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .